• 1. Acylarylnitrosamines. Part III. Decomposition of 2,5-di-(N-nitrosoacetamido)-1,4-di-t-butylbenzene and related compounds
  J. I. G. Cadogan,M. J. P. Harger,J. T. Sharp J. Chem. Soc. B 1971 602
• 2. Amine oxidation and the chemistry of quinone imines. Part I. 3-Methoxy-4-t-butylaniline
  R. K. Haynes,F. R. Hewgill J. Chem. Soc. Perkin Trans. 1 1972 396
• 3. Stepwise dissolution and composition determination of samples of multiple crystals using a dissolution medium containing aqueous alcohol and fluorocarbon phases
  Humphrey A. Moynihan,Declan Armstrong RSC Adv. 2019 9 21405
• 4. 774. The kinetics and mechanisms of aromatic halogen substitution. Part XVI. Rates and products of chlorination of biphenyl and some t-butyl-substituted biphenyls in acetic acid
  P. B. D. de la Mare,E. A. Johnson J. Chem. Soc. 1963 4076
• 5. Simple chip-based interfaces for on-line monitoring of supramolecular interactions by nano-ESI MS
  Monica Brivio,R. Edwin Oosterbroek,Willem Verboom,Albert van den Berg,David N. Reinhoudt Lab Chip 2005 5 1111

Introduction to N-Butyl-N-phenylacetamide (CAS No. 91-49-6)

N-Butyl-N-phenylacetamide, a compound with the chemical formula C₁₁H₁₅NO, is a derivative of acetamide featuring a butyl group and a phenyl group as substituents. This compound is identified by its unique CAS number, CAS No. 91-49-6, which serves as a critical identifier in chemical and pharmaceutical databases. The molecular structure of N-butyl-N-phenylacetamide consists of an amide functional group connected to a butyl chain and a phenyl ring, making it a versatile intermediate in organic synthesis and potential candidate for various applications in the pharmaceutical industry.

The synthesis of N-butyl-N-phenylacetamide typically involves the reaction between butanamidine and phenylacetic acid under controlled conditions. This process requires precise control of temperature, pressure, and catalyst selection to ensure high yield and purity. The compound's stability under different environmental conditions, such as temperature and humidity, is also a crucial factor to consider during its handling and storage. Industrial-scale production often employs specialized reactors and purification techniques to meet the stringent requirements of pharmaceutical applications.

In recent years, N-butyl-N-phenylacetamide has garnered attention in the field of medicinal chemistry due to its potential biological activities. Research has indicated that this compound may exhibit properties relevant to pain management, neuroprotection, and anti-inflammatory effects. These findings are supported by in vitro studies that demonstrate its interaction with specific biological targets, such as enzymes and receptors involved in pain signaling pathways. The phenyl group in its structure contributes to its ability to modulate these pathways, making it an attractive candidate for further investigation.

One of the most compelling aspects of N-butyl-N-phenylacetamide is its role as a building block in the development of novel therapeutic agents. Researchers have explored its utility in designing molecules that combine multiple pharmacological properties, enhancing efficacy while minimizing side effects. For instance, modifications to the butyl and phenyl groups have been investigated to optimize solubility, bioavailability, and target specificity. These efforts align with the broader trend in drug discovery toward rational design based on structural insights.

The pharmacokinetic profile of N-butyl-N-phenylacetamide is another area of active investigation. Studies have examined its absorption, distribution, metabolism, and excretion (ADME) properties using both computational modeling and experimental methods. Understanding these parameters is essential for predicting how the compound will behave in vivo and for designing effective dosing regimens. Preliminary data suggest that N-butyl-N-phenylacetamide may exhibit favorable pharmacokinetic characteristics, including moderate oral bioavailability and reasonable metabolic stability.

Furthermore, the environmental impact of N-butyl-N-phenylacetamide has been considered in recent research. Efforts have been made to develop sustainable synthetic routes that minimize waste generation and reduce reliance on hazardous reagents. Green chemistry principles have guided these initiatives, emphasizing efficiency, safety, and ecological responsibility. Such approaches not only benefit the environment but also enhance the economic viability of producing this compound on a larger scale.

The regulatory landscape for N-butyl-N-phenylacetamide is another critical factor influencing its development and commercialization. Compliance with guidelines set forth by agencies such as the FDA and EMA is essential for ensuring safety and efficacy before it can be approved for therapeutic use. Regulatory submissions often require extensive documentation detailing synthetic methods, quality control measures, and preclinical safety data. Companies developing this compound must navigate these requirements carefully to bring their products to market successfully.

In conclusion, N-butyl-N-phenylacetamide (CAS No. 91-49-6) represents a promising compound with diverse applications in pharmaceutical research and development. Its unique molecular structure offers opportunities for designing molecules with enhanced therapeutic potential, while ongoing studies continue to elucidate its biological activities and pharmacokinetic properties. As research progresses, this compound is likely to play an increasingly significant role in the discovery of new treatments for various diseases.

• 13691-22-0(1-(4-Aminophenyl)pyrrolidin-2-one)
• 4641-57-0(1-Phenyl-2-pyrrolidone)
• 529-65-7(Acetamide,N-ethyl-N-phenyl-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)